Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01030_DB01268> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01030_DB01268 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01030_DB01268 label "DDI between Topotecan and Sunitinib - The p-glycoprotein inhibitor, Sunitinib, may increase the bioavailability of oral Topotecan. A clinically significant effect is also expected with IV Topotecan. Concomitant therapy should be avoided. [drugbank_resource:DB01030_DB01268]" assertion.
- drugbank_resource:DB01030_DB01268 identifier "drugbank_resource:DB01030_DB01268" assertion.
- drugbank_resource:DB01030_DB01268 title "DDI between Topotecan and Sunitinib - The p-glycoprotein inhibitor, Sunitinib, may increase the bioavailability of oral Topotecan. A clinically significant effect is also expected with IV Topotecan. Concomitant therapy should be avoided." assertion.